Blog

Why Prior Authorization for Farxiga Matters and How to Get It ?

Insurance Company and Medication Overview

Healthcare providers often face the challenge of obtaining insurance prior authorization (PA) for certain medications, such as Farxiga (Dapagliflozin Propanediol), which is commonly prescribed for managing Type 2 diabetes. WellCare Medicare, a popular provider of Medicare Part D prescription drug coverage, requires PA to verify the drug’s necessity for the patient. Farxiga, a part of the SGLT2 inhibitor class, helps regulate blood sugar, support weight loss, and manage blood pressure. Providers often turn to Farxiga after more common medications have failed or caused side effects. However, insurance companies like WellCare require detailed evidence that other options have been exhausted before they will approve Farxiga. This guide will help doctors, nurses, and office administrators understand WellCare’s requirements and how to make a strong submission for Farxiga 5mg under WellCare Medicare.

Key Takeaways

• Document Alternative Treatments: WellCare needs a clear record of which medications were tried previously, what the outcomes were, and why they were inadequate.
• Provide Clinical Justification: Demonstrating Farxiga’s positive impact on the patient’s condition, and explaining why continuing with it is essential, is critical to approval.
• Attach Supporting Documentation: Medical records, lab results, and progress notes make a big difference in strengthening your case for PA approval.

Step-by-Step Process for Obtaining Prior Authorization

Let’s get into the details of each step, from initiating the request to securing WellCare’s approval.

1. Initiating the PA Process

To kick off the PA, I accessed WellCare Medicare’s electronic prior authorization platform. Most of us use CoverMyMeds for this, as it’s a centralized, user-friendly system that allows you to submit PA requests directly to insurers. CoverMyMeds helps reduce manual work by auto-populating many fields once the patient’s basic information is entered, saving time and minimizing the risk of errors.

From there, I selected the specific PA form for Farxiga under WellCare Medicare and started filling in the required details.

2. Entering Patient and Provider Details

Patient Information: The PA process begins with basic but essential patient data. I included:

• Name and Date of Birth: This confirms patient identity.
• Medicare ID: Ensures the patient is enrolled in a qualifying plan.
• Address and Contact Number: For WellCare’s records and any necessary follow-up.

Without these details, WellCare can’t verify eligibility or ensure that the request aligns with the patient’s Medicare plan specifics. It sounds simple, but one typo here could delay the process.

Provider Information: Next up, I entered the prescribing provider’s details:

• NPI (National Provider Identifier): This unique identifier links the provider to the patient’s request.
• Name, Address, and Contact Information: This allows WellCare to reach out directly if they have questions or need additional documentation.

Having complete and accurate provider information is just as important as the patient’s details. It’s surprising how many requests get held up because of missing or outdated provider contact info.

3. Filling in Drug-Specific Information

Medication Name: In this case, Dapagliflozin Propanediol (Farxiga) 5mg.

Quantity and Dosage: For this request, I indicated that the patient needed one 5mg tablet per day, with a monthly supply of 30 tablets. These specifics help WellCare understand the patient’s ongoing medication needs and ensure that the correct dosage aligns with the approved therapeutic use.

4. Answering Clinical Questions

The clinical section is where we really make the case for why Farxiga is necessary. WellCare’s PA form included several specific questions:

Primary Diagnosis Code (ICD-10): For this patient, I used E11.9 – Type 2 diabetes mellitus without complications. This code underscores that the patient is dealing with blood sugar management issues and needs a medication within the SGLT2 inhibitor class for additional control.

Previous Treatment Attempts: This is a key area where you want to be as thorough as possible. I documented that the patient had already tried two other diabetes medications:

• Jardiance: Another SGLT2 inhibitor that did not yield adequate glucose control.
• Metformin: A widely-used first-line treatment, which the patient discontinued due to gastrointestinal side effects that made it intolerable.

WellCare needs to see this history to understand that Farxiga isn’t just a convenient choice but a necessary one after other treatments have failed.

Request for Expedited Review: The form also asks if you want the request to be fast-tracked. In this case, because the patient’s blood glucose levels were moderately stable, we chose a standard review rather than requesting an expedited one. If the patient’s blood sugar had been dangerously unstable, we could have justified an expedited review to speed up approval.

5. Justifying the Need for Farxiga

Now, it’s time to make the case for why Farxiga is the right choice for this patient’s ongoing care. Here’s how I laid out the justification:

Stability and Efficacy with Farxiga: I highlighted that, since starting Farxiga, the patient’s blood glucose levels have improved, and they’ve experienced fewer side effects compared to other medications. This alone is a strong point in favor of continuing Farxiga, as it’s clear the patient’s health has benefited from it.

Documentation of Alternative Trials and Failures: I included a detailed history of past medications and the specific issues with each. WellCare wants a clear picture of why Farxiga is the next best option. This evidence of insufficient response and intolerance to previous treatments strengthens the case for Farxiga, showing that it isn’t just “another option” but a necessary step in managing the patient’s condition.

6. Uploading Supporting Documentation

Finally, I attached relevant documentation to back up the PA request. This included:

• Prescription Summary: To confirm the specific dosage and frequency.
• Recent HbA1c Levels: Demonstrating the patient’s blood sugar status and the progress since starting Farxiga.
• Records of Past Medication Trials: These records illustrate the patient’s journey through various treatments, showing a consistent need for something more effective.

Uploading these documents is crucial. While it may feel like extra work, having thorough supporting evidence significantly increases the chances of approval. Once everything was uploaded, I submitted the PA request to WellCare, which then acknowledged receipt and scheduled it for review.

ICD and CPT Codes Explanation

• ICD-10 Code E11.9: This code, for Type 2 diabetes mellitus without complications, is essential in demonstrating the medical need for a diabetes management medication like Farxiga.

Frequently Asked Questions (FAQs)

Q1: Why is Farxiga 5mg prescribed for this patient with Type 2 diabetes?
A1: Farxiga has shown effectiveness in lowering blood sugar, especially when first-line treatments have proven inadequate or caused side effects. It’s often chosen when patients need an additional or alternative option that better suits their specific health profile.

Q2: What criteria does WellCare Medicare consider for Farxiga PA approval?
A2: WellCare looks at the patient’s diagnosis, previous treatment history, and any documented improvements on Farxiga. They need to see that it’s a necessary part of the patient’s regimen, not just a first-time attempt.

Q3: Is an expedited review necessary for diabetes medications?
A3: An expedited review is available if the patient’s condition requires urgent attention. In this case, since the patient’s blood sugar was relatively stable, we went with a standard review. However, if there’s evidence of urgency, an expedited review can be justified.

What Did We Learn?

The case highlights the importance of documentation in obtaining a Physician Approval (PA) for Farxiga, an advanced diabetes medication. Documenting the patient’s history with other medications and their progress on Farxiga makes it easier to demonstrate the necessity of the drug. A well-documented approach can speed up the PA process and reduce back-and-forth with insurers. Healthcare providers must focus on patient care, but dealing with paperwork can take valuable time. Staffingly, Inc. specializes in handling PAs, medical data entry, and other administrative tasks.

Disclaimer

The information in our posts is meant to inform and educate both healthcare providers and readers seeking a better understanding of the prior authorization process. However, it is not a substitute for professional advice. Insurance requirements, policies, and approval processes can vary widely and change over time. For accurate guidance, healthcare providers should consult directly with insurers or use professional resources, while patients should reach out to their insurance providers or healthcare professionals for advice specific to their situation.

This content does not establish any patient-caregiver or client-service relationship. Staffingly, Inc. assumes no liability for actions taken based on information provided in these posts.

For tailored support and professional services,

please contact Staffingly, Inc. at (800) 489-5877

Email : support@staffingly.com.